ROS, Inflammation, and Cardioprotection in Type 2 Diabetes

2 型糖尿病中的 ROS、炎症和心脏保护

基本信息

  • 批准号:
    8701394
  • 负责人:
  • 金额:
    $ 49.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-15 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Type 2 diabetes (T2D) is rapidly becoming a global pandemic and is projected to afflict more than 300 million individuals worldwide by the year 2025. This disease constitutes a major independent risk factor for heart attack and myocardial cell death. The current lines of drug therapy are insufficient to control this devastating disease and its serious cardiovascular complications. Based on our ample preliminary data, the current project is designed to test the following central HYPOTHESIS: Chronic inhibition of phosphodiesterase-5 (PDE-5) protects T2D hearts through suppression of myocardial oxidative stress and inflammasome formation via the AMPK/Sirt1/PGC-1¿ signal transduction network that leads to induction of mitochondrial antioxidant enzyme - glutathione S-transferase kappa 1 (GSTK1) and improvement of mitochondrial function. We propose the following 3 specific aims. Aim 1: PDE-5 inhibition with tadalafil activates AMPK/Sirt1/PGC-1¿ signaling pathway and attenuates cell death (necrosis/apoptosis) and mitochondrial respiratory chain dysfunction following myocardial ischemia/reperfusion (I/R) in T2D. Using db/db and high fat diet (HFD)-fed T2D mice, we will demonstrate the effect of tadalafil treatment on a) AMPK phosphorylation, eNOS and nitric oxide generation; b) the possible loss of cardioprotection in the AMPK¿2 dominant negative transgenic mice following I/R; c) the role of AMPK in activating Sirt1 and PGC-1¿; and d) the potential interplay of cGMP-dependent protein kinase (PKG) and AMPK/Sirt1/PGC-1¿ signal transduction network in attenuation of cardiomyocyte apoptosis/necrosis and mitochondrial respiratory chain dysfunction following I/R. Aim 2: PDE-5 inhibition restores depressed level of mitochondrial GSTK1 in the T2D hearts and attenuates I/R injury via its antioxidant as well as lipid-regulating properties. Using GSTK1 knockout mice with HFD-induced T2D, we will demonstrate the causative role of GSTK1 in PDE-5 inhibitor-induced cardioprotection and lipid regulating properties in T2D. We will also induce targeted overexpression of GSTK1 by direct intramyocardial injection of adenoviral GSTK1 to demonstrate the direct cause and effect relationship of GSTK1 in reducing I/R injury in T2D hearts. Aim 3: PDE-5 inhibitors attenuate inflammation through suppression of inflammasome and inhibition of caspase-1 in diabetic heart. We will examine: a) the role of PDE-5 inhibitors in attenuating inflammosome formation with consequent inhibition of caspase-1 activity following I/R in the heart and cardiomyocytes; b) the role of AMPK and Sirt-1 in attenuation of inflammasome formation; c) the involvement of AMPK, GSTK1, and PKG1¿ in prevention of inflammasome formation following I/R. Overall, the proposed studies will pave the way to a potentially novel pharmacotherapy against inflammation and cardiac injuries resulting from T2D conditions.
描述(申请人提供):2型糖尿病(T2D)正在迅速成为一种全球大流行,预计到2025年将在全球范围内困扰超过3亿人。这种疾病是心脏病发作和心肌细胞死亡的主要独立危险因素。目前的药物治疗路线不足以控制这种毁灭性的疾病及其严重的心血管并发症。基于我们大量的初步数据,本项目旨在验证以下中心假设:慢性抑制磷酸二酯酶-5(PDE-5)通过AMPK/Sirt1/PGC-1信号转导网络抑制心肌氧化应激和炎症体形成,从而诱导线粒体抗氧化酶-谷胱甘肽S转移酶-kappa 1(GSTK1)的诱导,从而改善线粒体功能,从而保护T2D心脏。我们提出了以下三个具体目标。目的:他达拉非抑制PDE-5激活AMPK/Sirt1/PGC-1信号通路,减轻T2D心肌缺血/再灌注(I/R)后细胞死亡(坏死/凋亡)和线粒体呼吸链功能障碍。我们将利用db/db和高脂饮食(HFD)喂养的T2D小鼠,证明他达拉非对a)AMPK磷酸化、eNOS和一氧化氮生成的影响;b)AMPK?2显性阴性转基因小鼠在I/R后心脏保护的可能丧失;c)AMPK在激活Sirt1和PGC-1‘中的作用;和d)cGMP依赖的蛋白激酶(PKG)和AMPK/Sirt1/PGC-1信号转导网络在减轻I/R后心肌细胞凋亡/坏死和线粒体呼吸链功能障碍中的潜在相互作用目的2:PDE-5抑制恢复T2D心脏线粒体GSTK1的抑制水平,并通过其抗氧化和脂质调节特性减轻I/R损伤。利用GSTK1基因敲除小鼠的HFD诱导的T2D,我们将证明GSTK1在PDE-5抑制剂诱导的T2D的心脏保护和调脂特性中的致病作用。我们还将通过直接心肌内注射腺病毒GSTK1来诱导GSTK1的靶向性过表达,以证明GSTK1在减轻T2D心脏I/R损伤中的直接因果关系。目的:PDE-5抑制剂通过抑制炎症小体和抑制caspase-1来减轻糖尿病心脏炎症。我们将研究:a)PDE-5抑制剂在减轻心脏和心肌细胞I/R后caspase-1活性方面的作用;b)AMPK和Sirt-1在减轻炎性小体形成中的作用;c)AMPK、GSTK1和PKG1参与预防I/R后炎性小体形成。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rakesh C Kukreja其他文献

Sildenafil Citrate (Viagra) Induces Cardioprotective Effects after Ischemia/Reperfusion Injury in Infant Rabbits
柠檬酸西地那非(伟哥)可诱导幼兔缺血/再灌注损伤后的心脏保护作用
  • DOI:
    10.1203/01.pdr.0000147736.27672.15
  • 发表时间:
    2005-01-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Yvonne A Bremer;Fadi Salloum;Ramzi Ockaili;Eric Chou;William B Moskowitz;Rakesh C Kukreja
  • 通讯作者:
    Rakesh C Kukreja

Rakesh C Kukreja的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rakesh C Kukreja', 18)}}的其他基金

BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
BMP-7 调节糖尿病心肌和骨骼肌炎症诱导的细胞死亡
  • 批准号:
    9788441
  • 财政年份:
    2018
  • 资助金额:
    $ 49.36万
  • 项目类别:
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
BMP-7 调节糖尿病心肌和骨骼肌炎症诱导的细胞死亡
  • 批准号:
    10242150
  • 财政年份:
    2018
  • 资助金额:
    $ 49.36万
  • 项目类别:
Amelioration of Doxorubicin Induced Muscle Dysfunction with Embryoinic stem cells-Derived Exosomes
利用胚胎干细胞来源的外泌体改善阿霉素引起的肌肉功能障碍
  • 批准号:
    10322656
  • 财政年份:
    2018
  • 资助金额:
    $ 49.36万
  • 项目类别:
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
BMP-7 调节糖尿病心肌和骨骼肌炎症诱导的细胞死亡
  • 批准号:
    10376557
  • 财政年份:
    2018
  • 资助金额:
    $ 49.36万
  • 项目类别:
ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
2 型糖尿病中的 ROS、炎症和心脏保护
  • 批准号:
    8522552
  • 财政年份:
    2013
  • 资助金额:
    $ 49.36万
  • 项目类别:
Health Educational Research Opportunities (HERO)
健康教育研究机会(HERO)
  • 批准号:
    7797605
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
Health Educational Research Opportunities (HERO)
健康教育研究机会(HERO)
  • 批准号:
    7617652
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
磷酸二酯酶 5 抑制后的心脏保护信号传导
  • 批准号:
    8258744
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
磷酸二酯酶 5 抑制后的心脏保护信号传导
  • 批准号:
    7867829
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
Health Educational Research Opportunities (HERO)
健康教育研究机会(HERO)
  • 批准号:
    8056464
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:

相似海外基金

Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
  • 批准号:
    2348998
  • 财政年份:
    2025
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
  • 批准号:
    2348999
  • 财政年份:
    2025
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
Understanding Latin American Challenges in the 21st Century (LAC-EU)
了解拉丁美洲在 21 世纪面临的挑战 (LAC-EU)
  • 批准号:
    EP/Y034694/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Research Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
  • 批准号:
    2333724
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
  • 批准号:
    2346565
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
  • 批准号:
    2349580
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
  • 批准号:
    2346564
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
  • 批准号:
    2401164
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
  • 批准号:
    2412294
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
  • 批准号:
    2415059
  • 财政年份:
    2024
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了